Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kulkarni Samarth −$2.6M Chief Executive Officer sold 14% of stake
  2. KASINGER JAMES R. −$797K General Counsel and Secretary sold 12% of stake
  3. Behbahani Ali −$781K Director sold 45% of stake
  4. George Simeon −$720K Director sold 48% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-09-01 Bolzon Bradley J PhD Director Sale −19,135 $92.98 $1.8M 200
2020-09-01 Bolzon Bradley J PhD Director Sale −200 $93.74 $19K 0
2020-09-01 Bolzon Bradley J PhD Director Option exercise · Stock Option (Right to Buy) −30,000 30,000
2020-09-01 Bolzon Bradley J PhD Director Option exercise · Stock Option (Right to Buy) −15,000 15,000
2020-09-01 Bolzon Bradley J PhD Director Option exercise · Stock Option (Right to Buy) −15,000 15,000
2020-08-19 Novak Rodger President Option exercise +25,000 $14.00 $350K 673,007
2020-08-19 Novak Rodger President Sale −25,000 $100.00 $2.5M 648,007
2020-08-19 Novak Rodger President Option exercise · Stock Option (Right to Buy) −25,000 115,826
2020-08-13 Behbahani Ali Director Other acquisition +57 256
2020-08-13 Behbahani Ali Director Other acquisition +14 14
2020-08-03 TOMSICEK MICHAEL JOHN Chief Financial Officer Option exercise +12,000 $17.75 $213K 12,410
2020-08-03 TOMSICEK MICHAEL JOHN Chief Financial Officer Sale −6,552 $86.25 $565K 5,858
2020-08-03 TOMSICEK MICHAEL JOHN Chief Financial Officer Sale −5,448 $87.33 $476K 410
2020-07-07 Novak Rodger President Option exercise +5,586 $1.81 $10K 653,593
2020-07-07 Novak Rodger President Option exercise +19,414 $14.00 $272K 673,007
2020-07-07 Novak Rodger President Sale −25,000 $90.00 $2.3M 648,007
2020-07-07 Novak Rodger President Option exercise · Stock Option (Right to Buy) −5,586 0
2020-07-07 Novak Rodger President Option exercise · Stock Option (Right to Buy) −19,414 140,826
2020-07-06 Bolzon Bradley J PhD Director Sale −14,689 $82.16 $1.2M 559,501
2020-07-06 Bolzon Bradley J PhD Director Sale −5,311 $83.00 $441K 554,190

Page 41 of 46 · 910 trades